[1]佟嘉佳 王雨 王耀晨 孙凤志 张树龙 刘吉义.心房颤动导管消融治疗新进展:技术革新与未来展望[J].心血管病学进展,2025,(12):1057.[doi:10.16806/j.cnki.issn.1004-3934.2025.12.001]
 TONG Jiajia,WANG Yu,WANG Yaochen,et al.Advances in Catheter Ablation for Atrial Fibrillation:Technological Innovation and Future Expectation[J].Advances in Cardiovascular Diseases,2025,(12):1057.[doi:10.16806/j.cnki.issn.1004-3934.2025.12.001]
点击复制

心房颤动导管消融治疗新进展:技术革新与未来展望()

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2025年12期
页码:
1057
栏目:
综述
出版日期:
2025-12-25

文章信息/Info

Title:
Advances in Catheter Ablation for Atrial Fibrillation:Technological Innovation and Future Expectation
作者:
佟嘉佳1 王雨2 王耀晨2 孙凤志 2 张树龙2 刘吉义 2
(1.大连医科大学,辽宁 大连 116000;2.大连大学附属中山医院心脏中心心律失常科,辽宁 大连 116000)
Author(s):
TONG Jiajia1 WANG Yu2 WANG Yaochen2SUN Fengzhi2 ZHANG ShulongLIU Jiyi2
(1.Dalian Medical University,Dalian 116000,Liaoning,China2.Department of Cardiology,Affiliated Zhongshan Hospital of Dalian University,Dalian 116000,Liaoning,China)
关键词:
导管消融心房颤动磁导航脉冲电场消融人工智能
Keywords:
Catheter ablationAtrial fibrillationCryoballoon ablationPulsed electric field ablationArtificial intelligence
DOI:
10.16806/j.cnki.issn.1004-3934.2025.12.001
摘要:
心房颤动(房颤)作为全球范围内日益增长的心律失常疾病,增加了卒中和心力衰竭的风险,影响患者的生活质量,并给医疗系统带来了沉重的负担。目前,房颤的治疗主要包括抗心律失常药物和射频消融术。与药物治疗相比,导管消融在降低房颤复发风险、减少心血管住院率和死亡率等方面具有显著优势。近年来房颤消融技术不断进展,为患者提供了更优化的治疗选择。本文将重点综述房颤消融技术最新进展与临床应用,以期丰富房颤患者的治疗选择,进一步改善预后。
Abstract:
Atrial fibrillation (AF),as a growing global arrhythmia disorder,increases the risk of stroke and heart failure,impairs patients’ quality of life,and imposes a heavy burden on healthcare systems. Currently,the primary treatments for AF include antiarrhythmic drugs and radiofrequency ablation. Compared with pharmacological therapy,catheter ablation demonstrates significant advantages in reducing AF recurrence risk,decreasing cardiovascular hospitalization rates,and lowering mortality. In recent years,continuous advancements in AF ablation techniques have provided patients with more optimized treatment options. This article will focus on reviewing the latest progress and clinical applications of AF ablation technologies,aiming to expand therapeutic options for AF patients and further improve their prognosis.

参考文献/References:

[1] Feinberg WM,Blackshear JL,Laupacis A,et al. Prevalence,age distribution,and gender of patients with atrial fibrillation. Analysis and implications[J]. Arch Intern Med,1995,155(5):469-473.

[2] 中华医学会心血管病学分会,中国生物医学工程学会心律分会. 心房颤动诊断和治疗中国指南[J]. 中华心血管病杂志,2023,51(6):572-618.

[3] Tzeis S,Gerstenfeld EP,Kalman J,et al. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation[J]. J Interv Card Electrophysiol,2024,67(5):921-1072.

[4] Reinsch N,Füting A,Hartl S,et al. Pulmonary vein isolation using pulsed field ablation vs. high-power short-duration radiofrequency ablation in paroxysmal atrial fibrillation:efficacy,safety,and long-term follow-up (PRIORI study)[J]. Europace,2024,26(7):euae194.

[5] Dello Russo A,Compagnucci P,Anselmino M,et al. Pulsed field vs very high-power short-duration radiofrequency ablation for atrial fibrillation:Results of a multicenter,real-world experience[J]. Heart Rhythm,2024,21(9):1526-1536.

[6] Winkle RA,Mohanty S,Patrawala RA,et al. Low complication rates using high power (45-50 W) for short duration for atrial fibrillation ablations[J]. Heart Rhythm,2019,16(2):165-169.

[7] Akhtar T,Berger R,Marine JE,et al. Cryoballoon ablation of atrial fibrillation in octogenarians[J]. Arrhythmia Electrophysiol Rev,2020,9(2):104-107.

[8] Casella M,Dello Russo A,Russo E,et al. Biomarkers of myocardial injury with different energy sources for atrial fibrillation catheter ablation[J]. Cardiol J,2014,21(5):516-523.

[9] Reichlin T,Kueffer T,Knecht S,et al. PolarX vs Arctic Front for cryoballoon ablation of paroxysmal AF:the randomized COMPARE CRYO Study[J]. JACC Clin Electrophysiol,2024,10(7 Pt 1):1367-1376.

[10] Klaver M N,De Potter T J R,Iliodromitis K,et al. Ultralow temperature cryoablation using near-critical nitrogen for cavotricuspid isthmus-ablation,first-in-human results[J]. J Cardiovasc Electrophysiol,2021,32(8):2025-2032.

[11] Tohoku S,Schmidt B,Bordignon S,et al. Initial clinical experience of pulmonary vein isolation using the ultra-low temperature cryoablation catheter for patients with atrial fibrillation[J]. J Cardiovasc Electrophysiol,2022,33(7):1371-1379.

[12] Rovaris G,Ciconte G,Schiavone M,et al. Second-generation laser balloon ablation for the treatment of atrial fibrillation assessed by continuous rhythm monitoring:the LIGHT-AF study[J]. Europace,2021,23(9):1380-1390.

[13] Chun JKR,Bordignon S,Last J,et al. Cryoballoon versus laserballoon:insights from the first prospective randomized balloon trial in catheter ablation of atrial fibrillation[J]. Circ Arrhythm Electrophysiol,2021,14(2):e009294.

[14] Ciconte G,Schiavone M,Rovaris G,et al. Anatomical-guided third-generation laser balloon ablation for the treatment of paroxysmal atrial fibrillation assessed by continuous rhythm monitoring:results from a multicentre prospective study[J]. Europace,2024,26(11):euae263.

[15] Turagam MK,Neuzil P,Schmidt B,et al. Safety and effectiveness of pulsed field ablation to treat atrial fibrillation:one-year outcomes from the MANIFEST-PF registry[J]. Circulation,2023,148(1):35-46.

[16] Yavin H,Shapira-Daniels A,Barkagan M,et al. Pulsed field ablation using a lattice electrode for focal energy delivery:biophysical characterization,lesion durability,and safety evaluation[J]. Circ Arrhythm Electrophysiol,2020,13(6):e008580.

[17] Reddy VY,Anic A,Koruth J,et al. Pulsed field ablation in patients with persistent atrial fibrillation[J]. J Am Coll Cardiol,2020,76(9):1068-1080.

[18] Joglar JA,Chung MK,Armbruster AL,et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation:a report of the american college of cardiology/american heart association joint committee on clinical practice guidelines[J]. Circulation,2024,149(1):e1-e156.

[19] Reddy VY,Gerstenfeld EP,Schmidt B,et al. Pulsed field ablation for persistent?atrial?fibrillation:1-year results of ADVANTAGE AF[J]. J Am Coll Cardiol,2025,85(17):1664-1678.

[20] Reddy VY,Gerstenfeld EP,Schmidt B,et al. Pulsed field ablation of persistent atrial fibrillation with continuous electrocardiographic monitoring follow-up:ADVANTAGE AF phase 2[J]. Circulation,2025,152(1):27-40.

[21] Popa MA,Venier S,Menè R,et al. Characterization and clinical significance of hemolysis after pulsed field ablation for atrial fibrillation:results of a multicenter analysis[J]. Circ Arrhythmia Electrophysiol,2024,17(10):e012732.

[22] Medi C,Evered L,Silbert B,et al. Subtle post-procedural cognitive dysfunction after atrial fibrillation ablation[J]. J Am Coll Cardiol,2013,62(6):531-539.

[23] Bianchini L,Schiavone M,Vettor G,et al. Hybrid-convergent procedure or pulsed?field ablation in long-standing persistent atrial fibrillation[J]. JACC Clin Electrophysiol,2024,10(7 Pt 2):1700-1710.

[24] Chen S. Very high-power short duration 90 W/4?s (vHPSD) vs. vHPSD-combined ablation index-guided 50W ablation (hybrid) approach for pulmonary vein isolation in treating atrial fibrillation:have we found the best radiofrequency recipe?[J]. J Interv Card Electrophysio,2024,67(7):1483-1485.

[25] Noten AME,Romanov A,de Schouwer K,et al. Robotic magnetic navigation-guided catheter ablation establishes highly effective pulmonary vein isolation in patients with paroxysmal atrial fibrillation when compared to conventional ablation techniques[J]. J Cardiovasc Electrophysiol,2023,34(12):2472-2483.

[26] 刘晓宇,郑杰,李库林,等. 心房颤动冷冻球囊消融与磁导航指导下消融放射暴露对比研究[J]. 中华放射医学与防护杂志, 2023,43(7):547-553.

[27] Chen HH,Liu CM,Chang SL,et al. Automated extraction of left atrial volumes from two-dimensional computer tomography images using a deep learning technique[J]. Int J Cardiol,2020,316:272-278.

[28] Liu,Xun,Shen,Yan,Zhang,Su,et al. Segmentation of left atrium through combination of deep convolutional and recurrent neural networks[J]. J Med Imaging Health Inform,2018,8(8):1578-1584.

[29] Tang S,Razeghi O,Kapoor R,et al. Machine learning-enabled multimodal fusion of intra-atrial and body surface signals in prediction of atrial fibrillation ablation outcomes[J]. Circ Arrhythmia Electrophysiol,2022,15(8):e010850.

[30] Liu CM,Chang SL,Chen HH,ET AL. The clinical application of the deep learning technique for predicting trigger origins in patients with paroxysmal atrial fibrillation with catheter ablation[J]. Circ Arrhythm Electrophysiol,2020,13(11):e008518.

相似文献/References:

[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
 HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(12):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
 DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(12):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
 ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
 ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
 HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
 WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
 XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
 ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(12):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
 WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(12):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
 ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(12):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
[11]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
 WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(12):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
[12]赵磊 梁兆光.导管消融术后心房颤动复发的危险因素及预防[J].心血管病学进展,2019,(5):766.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.025]
 ZHAO LeiLIANG Zhaoguang.Risk Factors and Prevention of Atrial Fibrillation Recurrence after Catheterablation[J].Advances in Cardiovascular Diseases,2019,(12):766.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.025]
[13]辛小宇 梁兆光.心房颤动导管消融围术期抗凝治疗研究进展[J].心血管病学进展,2020,(8):809.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.007]
 XIN XiaoyuLIANG Zhaoguang.Perioperative Anticoagulation for Atrial Fibrillation Catheter Ablation[J].Advances in Cardiovascular Diseases,2020,(12):809.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.007]
[14]赵灿 吴永全.基于环肺静脉隔离的房颤导管消融策略选择治疗进展[J].心血管病学进展,2020,(12):1234.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.003]
 ZHAO Can,WU Yongquan.Catheter Ablation Strategies for Atrial Fibrillation Based on Circumferential Pulmonary Vein Isolation[J].Advances in Cardiovascular Diseases,2020,(12):1234.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.003]
[15]刘玉辉 王盼盼 陈椿.心房颤动性心肌病临床研究进展[J].心血管病学进展,2020,(12):1238.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.004]
 LIU Yuhui,WANG Panpan,CHEN Chun.Atrial Fibrillation-induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(12):1238.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.004]
[16]白金龙 李洪仕 蔡衡.非瓣膜性心房颤动导管消融术后抗凝策略的研究进展[J].心血管病学进展,2021,(1):30.[doi:10.16806/j.cnki.issn.1004-3934.201.01.000]
[17]那丞 黄织春.干预自主神经对心房颤动影响的研究进展[J].心血管病学进展,2021,(1):30.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
 NA Cheng,HUANG Zhichun.Effect of Autonomic Nerve Intervention on Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(12):30.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
[18]徐尧 蔡衡 李洪仕.心房颤动合并心力衰竭的导管消融治疗[J].心血管病学进展,2021,(4):322.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.009]
 XU Yao,CAI Heng,LI Hongshi.Role of Radiofrequency Ablation in Patients with Atrial Fibrillation and Heart Failure[J].Advances in Cardiovascular Diseases,2021,(12):322.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.009]
[19]袁明 谢瑞芹.导管消融对心房颤动患者生活质量影响的研究进展[J].心血管病学进展,2021,(10):884.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.005]
 YUAN MingXIE Ruiqin.Effect of Catheter Ablation on Quality of Life in patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(12):884.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.005]
[20]邹永伟 胡小恋.左房低电压与心房颤动相关性的研究进展[J].心血管病学进展,2022,(3):211.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
 ZHOU Yongwei,H U Xiaolian.The Correlation Between Left Atrial Low-Voltage Area and Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(12):211.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]

更新日期/Last Update: 2026-04-14